Search

Britain's privatised defence lab ties up with 7 universities, in a strategy to do more with fewer partners.

Nanonucleant, a spin-out of Imperial College London, is seeking angel financing to move ahead with a glass grain-based technology that aids in crystallising proteins for study as drug targets.

Reports of incubators' demise were premature

For her latest fortnightly funding column, Mary Lisbeth D'Amico set out to find European seed funders. That was as easy as finding a needle in a haystack.

The universities of Cambridge and Manchester, Imperial College London and the SETsquared Partnership, a joint venture among four universities in southern England, have won funding to collaborate with peers in the US and with companies such as Airbus and Boeing.

If you want to lead innovation in R&D, don’t neglect the crucial human factor, says Georges Haour from the IMD in Lausanne, Switzerland.

How to manage a virtual R&D team, valuing research – and other insights into R&D management.

Swati Piramal was born into a textile business family. And as typical Indian marriages were solemnized more than two decades ago, she too married into one of the oldest textile business families in Mumbai.

Nuala’s Moran’s roundup of news and views in the management of intellectual assets focuses on how to keep alliances happy

Wendy A. Choi, is a partner with intellectual property law firm Woodcock Washburn, focuses on US and foreign patent prosecution, transactions and licensing.

Adriana Vermut leads the San Francisco office for SpaceVest, a tech transfer-focused venture fund.

The first of six profiles of women leading the buiness of science: Jane Royston, software founder and professor

As the countries of the European Union struggle to meet their targets for R&D growth, they are looking at new tax breaks for entrepreneurs. Good news, or too little too late?

The official Irish government report on the failed Media Lab Europe project has focused attention another industry-academic research partnerships – one involving Bell Labs and a consortium of eight Irish universities.

A novel procedure for the preparation of β-lactams, from non-natural substrates.

This device delivers large molecules directly into cells, and even into specific sites within cells, whilst avoiding the cellular damage associated with other drug delivery methods.

Sigma-Aldrich, a US-based Nasdaq-listed life science company, has agreed to license a gene delivery technology from Oxford BioMedica and will pay $5 million for a stake in the spin out from Oxford University.

Michael Kenward's roundup of new studies, reports and tools for the business of science

Scientists love to complicate things; and if you're not in the same field, or – worse – are in business or investment, then it's easy to get lost. Enter the Science|Business Quick Guides to some of the hottest fields of science and technology…